Navigation Links
Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates

New Vice President Will lead Business Development and Communications for Company's International Line of Business

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Abt Associates announced that Valerie DeFillipo, a reproductive health and rights expert, has joined the company as Vice President for Business Development and Communications for its International Line of Business. DeFillipo joins Abt Associates from the International Planned Parenthood Federation (IPPF) in London, where for the last five years she served as Director of External Affairs.

"Valerie will play a significant role in helping us grow and diversify our international development portfolio," said Abt Associates Group Vice President for International Development, Tessie San Martin. "Her experience working with a variety of international donor governments and multi-lateral agencies, as well as her expertise in policy advocacy, communications and resource mobilization strengthens our business development capability. We are delighted to have her on our team."

While at IPPF DeFillipo was a lead organizer of the Countdown 2015 Global Roundtable; a founding board member of the Safe Abortion Action Fund, a global platform funded by multiple European donor governments to reduce maternal mortality in developing countries; and led IPPF's global rebranding effort.

Prior to joining IPPF, DeFillipo enjoyed a broad and varied career with Planned Parenthood Federation of America (PPFA). While there she directed the Miami and Florida Keys affiliate, founded the international public policy arm of PPFA, and led international business development, managing family planning clinics and providing training and technical assistance support to family planning programs in the Balkans, Middle East, Asia and the Caribbean.

An accomplished presenter and media spokesperson, DeFillipo has wide experience in strategic positioning, issue advocacy and communications campaigns as well as practical experience working with a range of donor governments, multi-lateral agencies and parliamentary groups on policy formulation and resource mobilization.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.

SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
2. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
3. Malaysian Healthcare Industry Is in Good Shape
4. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
5. 2009 is Healthy for Asia
6. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
7. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
9. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
10. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
11. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
Post Your Comments:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):